Adaptive Biotechnologies Corporation (1HM BE) stock market data APIs
€11.6309
0(0%)
as of March 18, 2026
Try our APIs with
free plan!
Adaptive Biotechnologies Corporation Financial Data Overview
Price chart is built with
Anychart
Prev. Close
11.6309
Open
11.6309
High
11.6309
Low
11.6309
52 wk Range
5.786-17.945
Market Cap
3 337 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Adaptive Biotechnologies Corporation data using free add-ons & libraries
Get Adaptive Biotechnologies Corporation Fundamental Data
Adaptive Biotechnologies Corporation Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get Adaptive Biotechnologies Corporation End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Adaptive Biotechnologies Corporation News
New
TD Cowen is Bullish on Adaptive Biotechnologies Corporation (ADPT)
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) is among the Most Volatile Stocks. On February 6, 2026, TD Cowen upgraded Adaptive Biotechnologies Corporation (NASDAQ:ADPT)’s price target to $21...
Assessing Adaptive Biotechnologies (ADPT) Valuation After Strong Recent Share Price Momentum
Adaptive Biotechnologies (ADPT) has drawn investor attention recently, with the share price at $18.07 and contrasting return numbers over the past year, month and past 3 months raising fresh questions...
Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results
Adaptive Biotechnologies Full year MRD revenue growth of 46% driven by clonoSEQ® testing volume SEATTLE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a com...
Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
Adaptive Biotechnologies SEATTLE, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics o...
Get Adaptive Biotechnologies Corporation fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
